Psoriatic Arthritis
Conference Coverage
Close monitoring of psoriasis patients can delay PsA onset
NEWPORT BEACH, CALIF. – A patient with psoriasis can develop crippling psoriatic arthritis (PsA) within 5 to 10 years of diagnosis, but monitoring...
From the Journals
PsA bone loss measurement: A surrogate for radiographic progression?
An advanced computer assisted digital x-ray radiogrammetry technique that measures bone thickness has the potential to be a surrogate marker of...
Conference Coverage
Tildrakizumab for psoriasis scores high marks in phase III
VIENNA – Tildrakizumab, a novel biologic for moderate to severe psoriasis, showed favorable efficacy and safety outcomes in two pivotal phase III...
Conference Coverage
Secukinumab for psoriasis at 4 years: undiminished efficacy and safety
VIENNA – Secukinumab showed reassuring safety with no drop-off in efficacy for psoriasis after 4 years of treatment.
Blog
Surgical Risks From Systemic Psoriasis Therapies
Treatment with systemic immunomodulatory agents commonly is employed in patients with moderate to severe plaque psoriasis and psoriatic arthritis...
Conference Coverage
Guselkumab achieves highest-ever response rates in psoriasis
VIENNA
Conference Coverage
Birth outcomes unaffected by paternal immunosuppressive therapy
VIENNA - Paternal use of systemic immunosuppressive agents in the months prior to conception didn't result in increased risk of preterm birth,...
From the Journals
Psoriasis not consistently linked to adverse pregnancy outcomes
Psoriasis was not consistently associated with adverse pregnancy outcomes across nine studies in a systematic review of the literature, but four...
News from the FDA/CDC
FDA approves biosimilar adalimumab
There are “no clinically meaningful differences” between Amgen’s biosimilar adalimumab (Amjevita) and AbbVie’s branded product Humira, the Food...
Conference Coverage
Shining a light on nonplaque psoriasis
Key clinical point: The Comprehensive Assessment of the Psoriasis Patient measure could expand the number of patients with moderate to severe...
Conference Coverage
Skin microbiome may differ in unique ways in psoriatic arthritis, psoriasis patients
Key clinical point:Changes in skin microbiome diversity in patients with psoriasis might someday help to predict progression to psoriatic...